Le J, Dam Q, Tran T, Nguyen A, Adler-Shohet F C, Kim S, Schmidt K, Lieberman J M, Bradley J S
University of California San Diego,Skaggs School of Pharmacy and Pharmaceutical Sciences,La Jolla,CA,USA.
Miller Children's and Women's Hospital,Long Beach,CA,USA.
Epidemiol Infect. 2017 Sep;145(12):2631-2639. doi: 10.1017/S0950268817001571. Epub 2017 Jul 27.
We sought to comprehensively assess the prevalence and outcomes of complications associated with Staphylococcus aureus bacteremia (SAB) in children. Secondarily, prevalence of methicillin resistance and outcomes of complications from methicillin-resistant S. aureus (MRSA) vs. methicillin-susceptible S. aureus SAB were assessed. This is a single-center cross-sectional study of 376 patients ⩽18 years old with SAB in 1990-2014. Overall, 197 (52%) patients experienced complications, the most common being osteomyelitis (33%), skin and soft tissue infection (31%), and pneumonia (25%). Patients with complications were older (median 3 vs. 0·7 years, P = 0·05) and more had community-associated SAB (66% vs. 34%, P = 0·001). Fewer patients with complications had a SAB-related emergency department or hospital readmission (10% vs. 19%, P = 0·014). Prevalence of methicillin resistance increased from 1990-1999 to 2000-2009, but decreased in 2010-2014. Complicated MRSA bacteremia resulted in more intensive care unit admissions (66% vs. 47%, P = 0·03) and led to increased likelihood of having ⩾2 foci (58% vs. 26%, P < 0·001). From multivariate analysis, community-associated SAB increased risk and concurrent infections decreased risk of complications (odds ratio (OR) 1·82 (1·1-3·02), P = 0·021) and (OR 0·58 (0·34-0·97), P = 0·038), respectively. In conclusion, children with SAB should be carefully evaluated for complications. Methicillin resistance remains associated with poor outcomes but have decreased in overall prevalence.
我们试图全面评估儿童金黄色葡萄球菌菌血症(SAB)相关并发症的患病率及转归情况。其次,评估了耐甲氧西林金黄色葡萄球菌(MRSA)与甲氧西林敏感金黄色葡萄球菌SAB的耐甲氧西林情况及并发症转归。这是一项针对1990 - 2014年间376例年龄≤18岁的SAB患者的单中心横断面研究。总体而言,197例(52%)患者出现并发症,最常见的是骨髓炎(33%)、皮肤及软组织感染(31%)和肺炎(25%)。出现并发症的患者年龄较大(中位年龄3岁对0.7岁,P = 0.05),且更多患者为社区相关性SAB(66%对34%,P = 0.001)。出现并发症的患者中因SAB再次到急诊科就诊或住院的较少(10%对19%,P = 0.014)。耐甲氧西林情况的患病率在1990 - 1999年至2000 - 2009年期间有所上升,但在2010 - 2014年有所下降。复杂的MRSA菌血症导致更多患者入住重症监护病房(66%对47%,P = 0.03),并使有≥2个感染灶的可能性增加(58%对26%,P < 0.001)。多因素分析显示,社区相关性SAB增加并发症风险,而并发感染降低并发症风险(比值比(OR)分别为1.82(1.1 - 3.02),P = 0.021)和(OR 0.58(0.34 - 0.97),P = 0.038)。总之,对于SAB患儿应仔细评估是否存在并发症。耐甲氧西林情况仍与不良转归相关,但总体患病率有所下降。